Clinical Trial Highlights

• Noninferiority of a Single-Tablet Combination HIV-1 Regimen Reported
• SC Ibalizumab Warrants Further Study for Preventing HIV-1 Infection
• Switching from RTV to COBI is Feasible in Patients with HIV-1 Who Have Mild-to-Moderate Renal Impairment
• Isavuconazole Promising for Cryptococcus spp Infections
• Voriconazole Safe and Effective in Children with IC, EC, and IA
• Isavuconazole Effective in UncCAs and HMs
• BMS-986001 is Effective Treatment for HIV-1-Infected Subjects
• Novel Single-Tablet Regimen Effective as Initial Treatment of HIV
• COBI Can Substitute for RTV in an HIV-1 Drug Regimen
• Safety and Efficacy of DTG Plus ABC/3TC for Treatment-Naïve Patients with HIV
• Doravirine 100 mg Dose Selected for Subsequent Studies Based on Exposure—Response Analysis
• No Resistance and Improved Renal and Bone Profiles with a Single-Table Regimen of D/C/F/TAF